AI Verdict
ISPR has stronger fundamentals based on our AI analysis.
ISPR vs ISCO Fundamental Comparison
| Metric | ISPR | ISCO |
|---|---|---|
| Revenue | $50.6M | $6.9M |
| Net Income | $-9.9M | $-70,000.0 |
| Net Margin | -19.5% | -1.0% |
| ROE | N/A | N/A |
| ROA | -11.7% | -1.3% |
| Current Ratio | 1.06x | 0.80x |
| Debt/Equity | N/A | N/A |
| EPS | $-0.17 | $-0.01 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ISPR vs ISCO: Frequently Asked Questions
Is ISPR or ISCO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ISPR has stronger fundamentals. ISPR is rated STRONG SELL (95% confidence) while ISCO is rated STRONG SELL (92% confidence). This is not investment advice.
How does ISPR compare to ISCO fundamentally?
Ispire Technology Inc. has ROE of N/A vs International Stem Cell CORP's N/A. Net margins are -19.5% vs -1.0% respectively.
Which stock pays higher dividends, ISPR or ISCO?
ISPR has a dividend yield of N/A or no dividend while ISCO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ISPR or ISCO for long term?
For long-term investing, consider that ISPR has STRONG SELL rating with 95% confidence, while ISCO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ISPR vs ISCO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ISPR vs ISCO, the AI consensus favors ISPR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.